Role of chitosan nanoparticles in the oral absorption of Gemcitabine

International Journal of Pharmaceutics

Volumn 437, Issue 1-2, 2012, Pages 172-177

  Derakhshandeh, Katayoun ^a   Fathi, Sahar ^a,b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chitosan; Gemcitabine; Intestinal absorption; Ionic gelation; Nanoparticle

Indexed keywords

CHITOSAN; GEMCITABINE; NANOCARRIER; NANOPARTICLE; TRIPOLYPHOSPHATE;

ANIMAL TISSUE; ARTICLE; CHELATION; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GELATION; IN VITRO STUDY; INTESTINE; INTESTINE ABSORPTION; MORPHOLOGY; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; ZETA POTENTIAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CALORIMETRY, DIFFERENTIAL SCANNING; CHITOSAN; DEOXYCYTIDINE; DRUG CARRIERS; INTESTINES; MALE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84865580061     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.08.008     Document Type: Article

References (30)

1. S. Aiba Studies on chitosan: lysozymic hydrolysis of partially N-acetylated chitosans Int. J. Biol. Macromol. 14 1992 225 228
2. G. Arya, M. Vandana, S. Acharya, and S.K. Sahoo Enhanced antiproliferative activity of Herceptin (HER2)-conjugated Gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy Nanomed. Nanotechnol. Biol. Med. 7 2011 859 870
3. L. Barthe, J.F. Woodley, S. Kenworthy, and G. Houin An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine Eur. J. Drug Metab. Pharmacokinet. 23 1998 313 323
4. E. Chu, and V.T. Devita Physicians' Cancer Chemotherapy Drug Manual. Publish No. 1 2007 Jones and Bartlett Publishers Toronto pp. 201-204
5. K. Derakhshandeh, A. Hosseinalizadeh, and M. Nikmohammadi The effects of PLGA microparticles on intestinal absorption of p-glycoprotein substrate using the everted rat intestinal sac model Arch. Pharm. Res. 34 2011 1989 1997
6. K. Derakhshandeh, M. Soheili, S. Dadashzadeh, and R. Saghiri Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients Int. J. Nanomed. 5 2010 463 471
7. Eli Lilly, Co. Summary of Product Characteristics: Gemcitabine, UK Prescribing Information 1997 Eli Lilly
8. V. Gandhi, and W. Plunkett Modulatory activity of 2′,2′- difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides Cancer Res. 50 1990 3675 3680
9. I. Gomez-Orellana Strategies to improve oral drug bioavailability Expert Opin. Drug Deliv. 2 2005 419 433
10. V. Heinemann, L.W. Hertel, G.B. Grindey, and W. Plankett Comparison of the cellular pharmacokinetics and toxicity of 2′,2′- difluorodeoxycytidine and 1-beta-d-arabino furanosylcytosine Cancer Res. 48 1988 4024 4031
11. L.W. Hertel, J.S. Kroin, J.W. Misner, and J.M. Tustin Synthesis of 2-deoxy-2′, 2′difluoro-d-ribose and 2-deoxy-2′, 2′difluoro-d-ribofuranosyl nucleosides J. Org. Chem. 53 1988 2406 2409
12. L.W. Hertel, G.B. Boder, J.S. Kroin, S.M. Rinzel, G.A. Poore, G.C. Todd, and G.B. Grindey Evaluation of the antitumor activity of Gemcitabine (2,2-difluoro-2-deoxycytidine) Cancer Res. 50 1990 4417 4422
13. P. Huang, S. Chubb, L.W. Hertel, G.B. Grindey, and W. Plunkett Action of 2′,2′-difluorodeoxycytidine on DNA synthesis Cancer Res. 51 1991 6110 6117
14. K. Janes, M. Fresneau, A. Marazuela, A. Fabra, and M. Alonso Chitosan nanoparticles as delivery systems for doxorubicin Int. J. Pharm. 295 2005 235 245
15. L. Jia, J. Zheng, S.h. Jiang, and K. Huang Preparation, physicochemical characterization and cytotoxicity in vitro of Gemcitabine-loaded PEG-PDLLA nanovesicles World J. Gastroenterol. 16 2010 1008 1013
16. O. Lacombe, J. Woodley, C. Solleux, J.M. Delbos, C. Boursier-Neyret, and G. Houin Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes Eur. J. Pharm. Sci. 23 2004 385 391
17. A. Maitra, T. Banerjee, S. Mitra, A. Singh, and R. Sharma Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles Int. J. Pharm. 243 2002 93 105
18. S. Majumdar, and A.K. Mitra Chemical modification and formulation approaches to elevated drug transport across cell membranes Expert Opin. Drug Deliv. 3 2006 511 527
19. Y. Masaoka, Y. Tanaka, M. Kataoke, S. Sakuma, and S. Yamashita Site of absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract Eur. J. Pharm. Sci. 29 2006 240 250
20. E. Mini, S. Nobili, B. Caciagli, I. Landini, and T. Mazzei Cellular pharmacology of Gemcitabine Ann. Oncol. 17 Suppl. 5 2006 v7 v12
21. P. Morandi Biological agents and Gemcitabine in the treatment of breast cancer Ann. Oncol. 17 Suppl. 5 2006 v177 v180
22. K. Nagpal, S.K. Singh, and D.N. Mishra Chitosan nanoparticles: a promising system in novel drug delivery Chem. Pharm. Bull. 58 2010 1423 1430
23. W. Paul, and C.P. Garside Chitosan, a drug carrier for the 21st century: a review STP Pharma Sci. 10 2000 5 22
24. W. Plunkett, P. Huang, and V. Gandhi Preclinical characteristics of Gemcitabine Anticancer Drugs 6 1995 7 13
25. K. Robinson, L. Lambiase, J. Li, C. Monteiro, and M. Schiff Fatal cholestatic liver failure associated with Gemcitabine therapy Dig. Dis. Sci. 48 2003 1804 1808
26. A.K. Sailaja, P. Amareshwar, and P. Chakravarty Chitosan nanoparticles as a drug delivery system RJPBCS 1 2010 474 484
27. A.M. Storniolo, S.R.B. Allerheiligen, and H.L. Pearce Preclinical, pharmacological, and phase I studies of Gemcitabine Semin. Oncol. 24 1997 S7-2-S7-7
28. I.M. Van der Lubben, J.C. Verhoef, A.C. Van Aelst, G. Borchard, and H.E. Junginger Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches Eur. J. Pharm. Sci. 14 2001 201 207
29. M. Vandana, and S.K. Sahoo Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles Nanomedicine (London) 4 2009 773 785
30. T.H. Wilson, and G. Wiseman The use of sacs of everted small intestine for the study of the transference of substance from the mucosal to the serosal surface J. Physiol. 123 1954 116 125